Researchers at Lancaster University have been awarded ?396,000 by the Medical Research Council to explore the possibility that the protein alpha-synuclein, which accumulates in parts of the brain affected by Parkinson's disease, can be detected in the blood and act as a marker for the disease.
请先注册再继续
为何要注册？
- 注册是免费的，而且十分便捷
- 注册成功后，您每月可免费阅读3篇文章
- 订阅我们的邮件
已经注册或者是已订阅？
Please or to read this article.